Aug 3 (Reuters) - Mithra Pharmaceuticals SA MITRA.BR :
* MITHRA RECEIVES EUR 1.25 MILLION MILESTONE PAYMENT FROM
FUJI
PHARMA UNDER ESTELLE® LICENSING AGREEMENT
* RELATES TO COMPLETION OF INTERIM CLINICAL STUDY REPORTS OF
PHASE
3 TRIALS IN PATIENTS WITH DYSMENORRHEA OR ENDOMETRIOSIS
* MARKS STRONG PROGRESS IN 2016 AGREEMENT AND FURTHER BOOSTS
MITHRA CASH POSITION
* MITHRA ELIGIBLE FOR REVENUE FROM SUPPLY OF MANUFACTURED
PRODUCT
POST-COMMERCIALIZATION
Source text for Eikon: ID:nGNE6kBkmB
Further company coverage: MITRA.BR
(Gdansk Newsroom)
((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))